News|Articles|November 20, 2025
Executive Summary: AI Everywhere: Architecting the Future of Clinical Trials
Author(s)Medidata
Key Takeaways
- Personalized treatment strategies are central to managing lung cancer brain metastases, enhancing patient outcomes.
- Targeted therapies and immunotherapies offer effective, less invasive alternatives to traditional treatments.
The clinical trial landscape is evolving at an incredible speed. The challenges are real; rising costs, data overload, and complex protocols can slow your progress. But what if you could face these challenges and turn them into a competitive advantage?
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
5